The ability of HDACi to create imbalance between DNA damage and DNA repair mechanisms was exciting, though the modest effect on Akt and Erk1/2 signaling suggested potential escape mechanisms which could be therapeutically exploited to enhance anti-tumor efficacy. The gene discussed is AKT1; the disease is neoplasm.